Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs)
100%
Cardiomyocytes
83%
Multi-walled Carbon Nanotubes (MWCNTs)
76%
Polyvinyl Alcohol
76%
Myocardial Infarction
76%
Degradation Rate
64%
Hydroxyapatite Scaffold
61%
Stem Cells
57%
Porosity
51%
Functional Groups
51%
Engineered Heart Tissue
46%
Contractility
46%
Fourier Transform Infrared Spectroscopy (FT-IR)
44%
Biocompatibility
44%
Multicentre Evaluation
38%
Automated Platform
38%
Cardiac Patch
38%
Hypomobility
38%
Human Pluripotent Stem Cells (hPSCs)
38%
Hypertrophic Cardiomyopathy
38%
CRISPR-Cas9 Editing
38%
Energy Depletion
38%
Drug Discovery
38%
Biomedicine
38%
Graphite
38%
Hyaluronic Acid
38%
Graphene Oxide
38%
Chitosan
38%
Induced Pluripotent Stem Cells (iPSCs)
38%
Physical Characterization
38%
Physicochemical Characteristics
38%
Tissue-engineered Constructs
38%
Oxide Materials
38%
Cell Tissue Culture
38%
Tissue Engineering Applications
38%
Putative Drug Targets
38%
Collagen Alginate
38%
Drug-induced
38%
Chemical Characterization
38%
Zinc Oxide
38%
Bioreactor System
38%
Cardiomyoplasty
38%
Evidence-based
38%
Scaffold for Tissue Engineering
38%
Bioreactor
38%
Rutile
38%
Reduced Graphene Oxide
38%
Platinum Coating
38%
Polyetheretherketone Implant
38%
Improved Biocompatibility
38%
Medicine and Dentistry
Tissue Regeneration
92%
Cardiac Muscle Cell
83%
Induced Pluripotent Stem Cell
76%
Biocompatible Material
69%
Antiinfective Agent
38%
Metal Ion
38%
Bone Tissue
38%
Cardiomyoplasty
38%
Engineered Tissue
38%
Amnion
38%
Fibroblast
38%
Antibiotics
38%
Myocardial Infarction
38%
Cardiovascular Disease
23%
Hydroxylapatite
23%
Health Care Cost
23%
Stem Cell
19%
Infarction
15%
Growth Factor
15%
Antibacterial Activity
15%
Bone Regeneration
15%
Engraftment
15%
Cell Viability Assay
12%
Stem Cell Therapy
12%
Tympanoplasty
12%
Anti-Inflammatory Drug
9%
Edetic Acid
9%
Cell Proliferation
9%
Fourier Transform Infrared Spectroscopy
9%
Immunocytochemistry
9%
Congestive Heart Failure
9%
Phosphate Buffered Saline
9%
Decellularization
9%
Eosin
9%
Functional Groups
9%
Haematoxylin
9%
Vimentin
9%
Myocardial Disease
9%
Ultrastructure
9%
Cell Viability
9%
Scanning Electron Microscopy
9%
Cell Adhesion
9%
Genome Engineering
7%
Safety Assessment
7%
Vancomycin
7%
Serositis
7%
Adverse Event
7%
In Vitro
7%
Cas9
7%
Gentamicin
7%